×
Akanda Long Term Debt 2021-2024 | AKAN
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Akanda long term debt from 2021 to 2024. Long term debt can be defined as the sum of all long term debt fields.
View More
Akanda Long Term Debt 2021-2024 | AKAN
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Akanda long term debt from 2021 to 2024. Long term debt can be defined as the sum of all long term debt fields.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$200B
Stryker (SYK)
$141B
Boston Scientific (BSX)
$128B
Medtronic (MDT)
$113B
EssilorLuxottica (ESLOY)
$112.7B
Lonza Group Ag (LZAGY)
$45.3B
Haleon (HLN)
$43.5B
GE HealthCare Technologies (GEHC)
$40.4B
ResMed (RMD)
$36.5B
Terumo (TRUMY)
$30.3B
Koninklijke Philips (PHG)
$25.9B
Zimmer Biomet Holdings (ZBH)
$21.6B
Baxter (BAX)
$18.4B
Insulet (PODD)
$17.2B
Smith & Nephew SNATS (SNN)
$10.8B
Bio-Rad Laboratories (BIO)
$10.4B
BellRing Brands (BRBR)
$8.9B
Demant (WILYY)
$8.4B
Lantheus Holdings (LNTH)
$6.1B
Haemonetics (HAE)
$4.4B
ICU Medical (ICUI)
$4.4B
TG Therapeutics (TGTX)
$4.3B
Prestige Consumer Healthcare (PBH)
$4B
Envista Holdings (NVST)
$3.7B
Perrigo (PRGO)
$3.7B
Neogen (NEOG)
$3.4B
Agios Pharmaceuticals (AGIO)
$3.1B
Shandong Weigao Medical Polymer (SHWGF)
$3B
GN Store Nord (GNNDY)
$2.9B
QuidelOrtho (QDEL)
$2.6B